NeuroRx Announces Zyesami™ (Aviptadil) Has Been Selected for Inclusion in NIH-Sponsored ...

Retrieved on: 2021-04-06 04:52:30

Tags for this article:

U.S. Securities and Exchange Commission

73rd United States Congress

Agencies of the United States government

Initial public offering

Prospectus

Securities Act

Proxy statement

Cycloserine/lurasidone

NeuroRx Inc.

Aviptadil

Click the tags to see associated articles and topics

NeuroRx Announces Zyesami™ (Aviptadil) Has Been Selected for Inclusion in NIH-Sponsored .... View article details on HISWAI: https://www.prnewswire.com/news-releases/neurorx-announces-zyesami-aviptadil-has-been-selected-for-inclusion-in-nih-sponsored-global-clinical-trial-to-include-aviptadil-and-remdesivir-301262506.html

Excerpt

... US Food and Drug Administration and will randomly allocate 640 participants to Aviptadil, Remdesivir, the combination of both drugs and placebo.

Article found on: www.prnewswire.com

View Original Article